Home
Pathology Industry
Drug Therapy Market and Forecasts, May 2013

Talk to Sam

+1 917 267 7886

Add to circles RSS feed

Publication dates

All regions

data types

All
- Company Data (5 852)
- Industry Data
- Country Data (1 522)

Reset your filters

Drug Therapy Market and Forecasts, May 2013

You might be interested in: clinical trial, cancer, drug, more »

1-11 of about 3 100 reports for Drug Therapy

Skin Care in Canada

Industry report
July 2012
3 pages

The Skin Care in Canada Sector Capsule is a briefing which provides headlines, market trends, company shares, forecasting, competitive analysis and brand information, for this...

Industries: Skin Care Products
Countries: Canada

Therapy Key Market Figures in China

Industry report
September 2012
21 pages

... Of sample, 21.3% After extrapolation), while local ablation was used in 5.4% Of sample and 4.0% After extrapolation. The usage of surgical therapy ( liver resection and transplantation), as well ...

Industries: Therapy
Countries: China

Generic Drug Sector

Industry report
January 2011
4 pages

... To monitor drug price changes in contrast to drug rebate reports furnished by third party administrators. Tracking prescription plan drug spend against quarterly state level prescription price changes ...

Industries: Generic Drug

Drug and Medication Sector in Qatar

Industry report
July 2011
38 pages

... And the most convenient drug therapy available, so medication can be taken as intended and achieve the goals of therapy essential to ensure that patients have the highest possible quality of life- strand l et ...

Industries: Drug and Medication
Countries: Qatar

U.S. Interferon Sector

Industry report
January 2011
34 pages

... Such as comorbidities and demographic profile The continued development of new treatment strategies, including the testing of the all-oral interferon-sparing therapies that may be available in the coming years ...

Industries: Drug and Medication
Countries: United States

Drug Sector Overview

Industry report
July 2012
24 pages

... Indicates that the drug may demonstrate substantial improvement over existing therapies on 1 or more clinically significant endpoints, such as substantial treatment effects observed early in clinical ...

Industries: Drug and Medication

U.S. Drug Industry

Industry report
June 2011
26 pages
by Trade Association

... Are not required to report plans to discontinue a product unless they are the sole manufactu of a drug that is life-supporting; life-sustaining; or intended for use in the prevention of a debilitating disease ...

Industries: Drug and Medication
Countries: United States

U.S. Drug Market : Innovation and Technology Trends

Industry report
November 2012
24 pages

... Something has to give. Affordable cost-effective = methods of pricing a drug Cost of production + roi Cost of production + r&d + roi Cost of alternative therapies (e.G., Diet, surgery, exercise, group ...

Industries: Drug and Medication
Countries: United States

Drug Delivery Technology Business

Industry report
September 2012
20 pages

... Difficult to address because the blood brain barrier excludes most drugs (and all biologics) from entering brain Despite a significant number of drug targets and funding, most drugs aimed ...

Industries: Drug Delivery Technology

Gene Therapy Sector Overview

Industry report
May 2011
20 pages
by Governmental Agency

... Challenges: Small and younger disease populations Natural history variable New therapies/treatment modalities where safety is not as well established Functional vision endpoints: Capture ...

Industries: Biological Therapy

U.S. Drug Market : Innovation and Technology Trends

Industry report
October 2012
45 pages

... October 22, 2012 wayne weart, pharmd cost effective drug therapy blood pressure goals Most important goal is to control the bp If at all possible use evidence-based medications and doses that have ...

Industries: Drug and Medication
Countries: United States

<<
< Previous
1
2
3
4
5
6
7
8
9
10
100
Next >
>>

» Purchase Premium Reports (From $ 125 - $ 7 600)

25 reports for Drug Therapy

Treatment Algorithms: Postherpetic Neuralgia - Lyrica forms the cornerstone of treatment for postherpetic neuralgia

$ 7 600
Industry report
November 2012
by Datamonitor

Prescribing trends reveal that patients with PHN are typically initiated on monotherapy. Since no single therapy provides sufficient efficacy, physicians increasingly turn to combination therapy at late ...

4 Companies for Drug Therapy